Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
Grant Life Sciences announces collaboration with Cleveland Clinic subsidiary
March 31st, 2005
Grant Life Sciences, Inc., (GLIF) announced an agreement with Allogen Laboratories, a wholly owned subsidiary of the Cleveland Clinic Foundation, wherein Allogen will perform testing and validation studies on Grant's protein-based human papillomavirus (HPV)/cervical cancer diagnostic technology and kits. As a part of the agreement, Allogen will screen precancerous and cervical cancer patient samples with Grant's proprietary test to determine the efficacy of the technology. The test, which consists of synthetic peptides derived from human papillomavirus proteins, would be the first diagnostic to directly detect cervical cancer. Dr. Daniel Cook,...
Source: Women's Health Weekly (2005-03-31)
|
